|
FDA Doubts Studies by CRO Cetero After Finding Data Falsification
The FDA is notifying pharmaceutical companies that testing conducted by Cetero Research in support of marketing applications may need to be repeated after agency investigations called five years of data into question.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives